- Nachrichtendetail
-
20.06.2024 14:10:15 - dpa-AFX: *J&J : TREMFYA PHASE 3 CROHN'S DISEASE STUDY ACHIEVES ALL PRIMARY AND SECONDARY ENDPOINTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Johnson & Johnson | 853260 | NYSE | 146,030 | 02.07.24 22:00:05 | -0,410 | -0,28% | 145,500 | 146,200 | 146,430 | 146,440 |
